Brian R. Lane, M.D., Ph.D., is the Director of Minimally-Invasive Surgery at Spectrum Health, Clinical Associate Professor in the Department of Surgery at Michigan State University College of Human Medicine and Co-director of Urologic Oncology at the Spectrum Health Cancer Program in Grand Rapids, Michigan. He graduated cum laude from Yale University before completing both M.D. and Ph.D. degrees at the University of Michigan. He then completed a residency in Urology and fellowship in Urologic Oncology at Cleveland Clinic. Dr. Lane’s clinical interests include surgical and multidisciplinary management of genitourinary cancers, including kidney, prostate, bladder and testicular cancer. He performs robot-assisted laparoscopic surgery, including partial nephrectomy, prostatectomy and cystectomy, as well as open, laparoscopic and laparo-endoscopic single site (LESS) surgery for benign and malignant urologic diseases.
His research has focused on characterizing molecular factors involved in angiogenesis and kidney cancer and predicting outcomes in patients with urologic cancer. For his research, he was named an American Urologic Association Foundation Research Scholar, participated in the Clinical Research Scholar’s Program at Case Western Reserve University and was awarded a Crile Research Fellowship from Cleveland Clinic. He has also been the recipient of fellowships from the Medical Scientist Training Program and the Mustard Seed Foundation. He is a former member of the ACGME Residency Review Committee for Urology and current member of the ACGME Milestones Committee for Urology. He has authored over 80 publications in peer-reviewed journals, several book chapters, and a book entitled “100 Questions & Answers about Kidney Cancer”.